Matthew Cox
Otology & Neurotology Physician in Winter Park, Florida.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 344 in Otology & Neurotology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Matthew Cox filed 1,783 Medicare Part D claims in 2024 as an Otology & Neurotology Physician in Winter Park, Florida, prescribing 98% generic.
- 2K
- Part D claims, 2024
- 98%
- generic prescribing
- Likely
- board-certified (heuristic)
- ≥82nd
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Matthew Cox
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1457643793), first enumerated 05/04/2011.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 1,783 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
3 CMS Care Compare hospital affiliations on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$266.12 in reported industry payments (9 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- State context
State board disciplinary context
Florida statewide board action statistics are published annually — these figures describe aggregate state activity, not Matthew Cox's individual license status. Verify directly with the state medical board.
Source: FLDOH annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1457643793 · Otology & Neurotology Physician
NPI-10 · ENUM-MID · TAX-TRACE · RX-MID · BOOK-THIN · PHOTO-ENUM
- NPI-10 1457643793
- ENUM-MID 2011
- TAX-TRACE 344
- RX-MID 1,783
- BOOK-THIN 28 in Florida
- PHOTO-ENUM Sameer Ahmed, M.D. · 2011
Matthew Cox's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
1,783 ≥ 82nd percentile 82% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
Matthew Cox practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 3 hospital affiliations - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Matthew Cox?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Florida
How Otology & Neurotology Physician compares to other specialties among Florida providers
Otology & Neurotology Physician ranks #353 among Florida's specialties (0% of in-state providers)
Each bar is a specialty's share of the Florida provider total, by primary NUCC taxonomy. The highlighted bar is Otology & Neurotology Physician; the long tail of smaller specialties is omitted for legibility.
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Otology & Neurotology Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1457643793 |
|---|---|
| Specialty | Otology & Neurotology Physician |
| Gender | Male |
| NPI Issued | 05/04/2011 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Matthew Cox's current license status, disciplinary history, and board certifications with the Florida Board of Medicine in Florida before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1457643793 is the unique 10-digit identifier CMS uses to link Cox across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
Hospital and facility affiliations
Facilities where Matthew Cox bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
According to CMS billing records, Matthew Cox is affiliated with 3 Medicare-billing facilities.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Matthew Cox. Source: openpaymentsdata.cms.gov.
Total received
$266
Largest payer
GENZYME CORPORATION
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Florida FLDOH 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 - they are NOT specific to Matthew Cox. To verify Matthew Cox's current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Generic-heavy
2% brand-name claims vs 98% generic, on 1,783 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
Prescribing Breakdown
- 30-Day Fills
- 2,370.267
- Total Day Supply
- 52,078
- Brand vs Generic
- 2% brand / 98% generic
- Brand Drug Cost
- $15K
- Generic Drug Cost
- $33K
- Opioid Claims
- 65 (3.6% rate)
- Antibiotic Claims
- 191
Patient Demographics
- Average Patient Age
- 72.5 years
- Avg HCC Risk Score
- 1.38
- Gender Split
- 60% female / 40% male
- Age Distribution
- <65: 58, 65-74: 336, 75-84: 189, 85+: 41
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Matthew Cox prescribes most
Top Medicare Part D drugs by claim count, 2024
- Azelastine Hcl
Azelastine Hcl
310 claims
- Ipratropium Bromide
Ipratropium Bromide
226 claims
- Fluticasone Propio…
Fluticasone Propionate
187 claims
- Levocetirizine Dih…
Levocetirizine Dihydrochloride
163 claims
- Ofloxacin
Ofloxacin
159 claims
- Prednisone
Prednisone
135 claims
- Ondansetron Odt 70
Ondansetron Odt
70 claims
- Oxycodone-Acetamin… 63
Oxycodone-Acetaminophen
63 claims
| Drug | Claims |
|---|---|
| Azelastine Hcl | 310 |
| Ipratropium Bromide | 226 |
| Fluticasone Propionate | 187 |
| Levocetirizine Dihydrochloride | 163 |
| Ofloxacin | 159 |
| Prednisone | 135 |
| Ondansetron Odt Ondansetron | 70 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 63 |
| Triamcinolone Acetonide | 51 |
| Ciprofloxacin Hcl | 49 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Otology & Neurotology Physician Overview
How Matthew Cox fits within the Otology & Neurotology Physician landscape nationally.
Matthew Cox's 1,783 claims are above the specialty average of 421.
Nationwide Otology & Neurotology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Cox, both outside Florida so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2011)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Otology & Neurotology Physician Providers in Florida
Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as Cox.
One of 28 Otology & Neurotology Physician providers enrolled in Florida, 5 are shown here.
Compare Otology & Neurotology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Matthew Cox's specialty? ▼
How much does Matthew Cox prescribe under Medicare Part D? ▼
Where is Matthew Cox located? ▼
What is Matthew Cox's NPI number? ▼
Does Matthew Cox prescribe more brand-name or generic drugs? ▼
Does Matthew Cox prescribe opioids? ▼
How many Otology & Neurotology Physician providers are there in the US? ▼
What drugs does Matthew Cox prescribe most often? ▼
Does Matthew Cox accept Medicare? ▼
How can I verify Matthew Cox's credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.
Published by
PlainDoctor
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.